MX2009003324A - Inmuno-reguladores, preparaciones y composiciones que incluyen los inmuno-reguladores, pruebas para evaluar la actividad de los inmuno-reguladores y preparaciones y composiciones que incluyen los mismos y metodos. - Google Patents

Inmuno-reguladores, preparaciones y composiciones que incluyen los inmuno-reguladores, pruebas para evaluar la actividad de los inmuno-reguladores y preparaciones y composiciones que incluyen los mismos y metodos.

Info

Publication number
MX2009003324A
MX2009003324A MX2009003324A MX2009003324A MX2009003324A MX 2009003324 A MX2009003324 A MX 2009003324A MX 2009003324 A MX2009003324 A MX 2009003324A MX 2009003324 A MX2009003324 A MX 2009003324A MX 2009003324 A MX2009003324 A MX 2009003324A
Authority
MX
Mexico
Prior art keywords
immune modulators
preparations
compositions
compositions including
immune
Prior art date
Application number
MX2009003324A
Other languages
English (en)
Inventor
Calvin W Mccausland
David Lisonbee
Richard H Bennett
Brent M Vaughan
Shane M Lefler
Original Assignee
4Life Res Lc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 4Life Res Lc filed Critical 4Life Res Lc
Publication of MX2009003324A publication Critical patent/MX2009003324A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70514—CD4

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)

Abstract

Se describen composiciones que incluyen extractos de fuentes de inmuno-reguladores que incluyen el inmuno-regulador de moléculas inmuno-reguladoras de nanofracción (por ejemplo, moléculas que tienen pesos moleculares de aproximadamente 3,000 Da o menores). Estas composiciones también pueden incluir otros inmuno-reguladores, tales como el factor de transferencia. La administración de las composiciones con extractos que incluyen moléculas inmuno-reguladoras de nanofracción regulan la inmunidad portada por las células (por ejemplo, regulan de manera descendente la actividad indeseada de la célula T), de un sujeto al cual son administradas dichas composiciones. Cuando son administradas con el factor de transferencia, la combinación de las moléculas inmuno-reguladoras de nanofracción en el factor de transferencia regula de manera descendente la actividad no deseada de la célula T mientras que aumentan o regulan de manera ascendente, la actividad de la célula T en contra de los patógenos y otras entidades no deseables, tales como células cancerosas y otras células aberrantes o mutadas. También se describen ensayos y técnicas de ensayo para evaluar las capacidades de la inmuno-regulación de diferentes substancias.
MX2009003324A 2006-09-29 2007-09-19 Inmuno-reguladores, preparaciones y composiciones que incluyen los inmuno-reguladores, pruebas para evaluar la actividad de los inmuno-reguladores y preparaciones y composiciones que incluyen los mismos y metodos. MX2009003324A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84834806P 2006-09-29 2006-09-29
US11/855,944 US10471100B2 (en) 2006-09-29 2007-09-14 Nanofraction immune modulators, preparations and compositions including the same, and associated methods
PCT/US2007/078947 WO2008042604A2 (en) 2006-09-29 2007-09-19 Immune modulators, preparations and compositions including immune modulators, tests for evaluating the activity of immune modulators and preparations and compositions including the same, and methods

Publications (1)

Publication Number Publication Date
MX2009003324A true MX2009003324A (es) 2009-06-30

Family

ID=39261440

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009003324A MX2009003324A (es) 2006-09-29 2007-09-19 Inmuno-reguladores, preparaciones y composiciones que incluyen los inmuno-reguladores, pruebas para evaluar la actividad de los inmuno-reguladores y preparaciones y composiciones que incluyen los mismos y metodos.

Country Status (15)

Country Link
US (2) US10471100B2 (es)
EP (1) EP2068913B1 (es)
JP (3) JP5592651B2 (es)
CN (1) CN101553247B (es)
AU (1) AU2007305076B2 (es)
CO (1) CO6220833A2 (es)
EC (1) ECSP099296A (es)
ES (1) ES2658107T3 (es)
HK (1) HK1138181A1 (es)
MX (1) MX2009003324A (es)
MY (2) MY158857A (es)
RU (2) RU2518341C2 (es)
SG (1) SG160430A1 (es)
TW (1) TWI449530B (es)
WO (1) WO2008042604A2 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6866868B1 (en) * 2003-09-15 2005-03-15 4Life Research, Lc Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions
US9028882B2 (en) 2005-05-02 2015-05-12 4Life Patents, Llc Nutraceutical gels
WO2006119408A1 (en) * 2005-05-02 2006-11-09 4Life Patents, Llc Transfer factor preparations and associated methods
US10471100B2 (en) * 2006-09-29 2019-11-12 4Life Patents, Llc Nanofraction immune modulators, preparations and compositions including the same, and associated methods
TW201105966A (en) * 2009-05-05 2011-02-16 4Life Patents Llc Methods and systems for assaying, maintaining, and enhancing the activity of the immune system of a subject
DK2643017T3 (da) 2010-11-23 2019-08-26 Pantheryx Inc Sammensætninger og fremgangsmåder ved behandling i udifferentierede eller blandede kliniske anvendelser med bredt spektrum
CN102172360B (zh) * 2011-02-17 2013-04-24 南京大学 一种牛初乳提取物及其提取方法和应用
WO2013039373A2 (es) * 2011-09-13 2013-03-21 Zepeda Lopez Hector Manuel Extracto dializado de leucocitos de origen bazo de tiburón, para la obtención de factor de transferencia potencializado, y método de extracción, comprobación y conteo del mismo
WO2013039374A2 (es) * 2011-09-15 2013-03-21 Zepeda Lopez Hector Manuel Método de extracción, comprobación y conteo de extracto dializado de leucocitos de origen bazo de tiburón, para la obtención de factor de transferencia potencializado, específicamente diseñado para su uso como tratamiento contra la enfermedad conocida como vitíligo
WO2013043033A2 (es) * 2011-09-19 2013-03-28 Zepeda Lopez Hector Manuel Método de extracción, comprobacíon de extracto dializado de leucocitos de origen bazo de tiburón, para la obtención de factor de transferecia potencializado, específicamente diseñado para su uso como adyuvante potencializador de vacunas virales
WO2013043032A2 (es) * 2011-09-19 2013-03-28 Zepeda Lopez Hector Manuel Extracto dializado de leucocitos de origen bazo de tiburón para la obtención de factor de transferencia potencializado, específicamente diseñado para su uso como inmunomodulador y método de extracción, comprobación y conteo del mismo
WO2013058640A2 (es) * 2011-10-20 2013-04-25 Zepeda Lopez Hector Manuel Método de extracción, comprobación y conteo de extracto dializado de leucocitos de origen bazo de tiburón, para la obtención de factor de transferencia potencializado, específicamente diseñado para su uso como tratamiento contra la enfermedad conocida como asma
MX338863B (es) * 2011-12-16 2016-05-01 Inst Politecnico Nacional Metodo de obtencion de extracto dializable de leucocitos.
US9566305B2 (en) * 2013-10-13 2017-02-14 4Life Patents, Llc Therapeutic compositions and methods for addressing physiological stresses and aging
KR101597540B1 (ko) * 2014-01-22 2016-02-29 건국대학교 산학협력단 난황 추출물을 유효성분으로 함유하는 면역증강용 조성물
JP7352539B2 (ja) * 2017-06-15 2023-09-28 ミラディーエックス 免疫療法に対する腫瘍応答およびその毒性を予測するためのバイオマーカー
US10933097B1 (en) 2020-03-05 2021-03-02 King Saud University Method of treating a bacterial infection using colostrum

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4402938A (en) * 1980-05-29 1983-09-06 Impro Products, Inc. Food and the method of extracting the same from colostrum and milk
US4816563A (en) 1983-11-25 1989-03-28 Amtron, Inc. Process for obtaining transfer factor from colostrum, transfer factor so obtained and use thereof
JPS60208919A (ja) * 1983-11-25 1985-10-21 アムトロン・インコ−ポレイテツド トランスフア−フアクタ−を初乳から得る方法、こうして得られたトランスフア−フアクタ−及びその使用
US5585098A (en) 1993-11-23 1996-12-17 Ovimmune, Inc. Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants
AU724703B2 (en) 1996-03-26 2000-09-28 Cylex, Inc. Methods for measurement of lymphocyte function
CA2249448C (en) 1996-03-26 2003-10-28 Dcv Biologics L. P. Egg anti-inflammatory composition, method of isolation and use
US7169571B2 (en) 1997-09-12 2007-01-30 Cylex, Inc. Methods for measurement of lymphocyte function
CZ287956B6 (cs) * 1997-11-04 2001-03-14 Medipharm Cz, S. R. O. Perorální přípravek k prevenci a léčbě parvovirózy psů
US20020044942A1 (en) 2000-09-18 2002-04-18 Chisolm Biological Laboratory, Llc Transfer factor composition and process for producing same
US6468534B1 (en) 2000-09-21 2002-10-22 4Life Research, Lc Methods for obtaining transfer factor from avian sources, compositions including avian-generated transfer factor, and methods of use
WO2002038164A1 (en) 2000-11-08 2002-05-16 Lorus Therapeutics Inc. Combination preparation of a biological response modifier and an anticancer agent and uses thereof
US20030003117A1 (en) 2001-06-18 2003-01-02 Michael Marenick Hydrolyzed whole egg products & related methods
WO2003068152A2 (en) 2002-02-11 2003-08-21 Arkion Life Sciences Llc Purified cytokine inhibitory factor
US20040005327A1 (en) 2002-05-16 2004-01-08 Subramanian Iyer Immune T-cell stimulation
AU2003295395A1 (en) 2002-11-04 2004-06-07 4Life Research, Lc Compositions, systems, and methods for focusing a cell-mediated immune response
CN1460522A (zh) 2003-06-16 2003-12-10 郭占军 预防和治疗疾病的蛋黄抗体组合物及其制备方法
US6866868B1 (en) 2003-09-15 2005-03-15 4Life Research, Lc Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions
US10471100B2 (en) 2006-09-29 2019-11-12 4Life Patents, Llc Nanofraction immune modulators, preparations and compositions including the same, and associated methods
CN100502674C (zh) 2005-10-13 2009-06-24 复旦大学 一种牛初乳和香菇提取物组合物及其制备方法和用途

Also Published As

Publication number Publication date
EP2068913A4 (en) 2009-12-02
JP6401744B2 (ja) 2018-10-10
CN101553247B (zh) 2015-08-19
RU2014102562A (ru) 2015-08-20
JP2016196491A (ja) 2016-11-24
RU2518341C2 (ru) 2014-06-10
MY158857A (en) 2016-11-15
EP2068913B1 (en) 2017-11-01
US20080081076A1 (en) 2008-04-03
AU2007305076B2 (en) 2011-04-28
WO2008042604A2 (en) 2008-04-10
ES2658107T3 (es) 2018-03-08
SG160430A1 (en) 2010-04-29
JP2014129413A (ja) 2014-07-10
US10471100B2 (en) 2019-11-12
US11197894B2 (en) 2021-12-14
TWI449530B (zh) 2014-08-21
WO2008042604A3 (en) 2008-11-06
MY188915A (en) 2022-01-13
RU2009116274A (ru) 2010-11-10
EP2068913A2 (en) 2009-06-17
CN101553247A (zh) 2009-10-07
US20200069737A1 (en) 2020-03-05
TW200831116A (en) 2008-08-01
CO6220833A2 (es) 2010-11-19
RU2619555C2 (ru) 2017-05-16
ECSP099296A (es) 2010-02-26
HK1138181A1 (zh) 2010-08-20
JP5592651B2 (ja) 2014-09-17
JP2010504988A (ja) 2010-02-18
AU2007305076A1 (en) 2008-04-10

Similar Documents

Publication Publication Date Title
MY188915A (en) Immune modulators, preparations and compositions including immune modulators, tests for evaluating the activity of immune modulators and preparations and compositions including the same and methods
BRPI0503828A (pt) formulações contendo pó, aquosas, lìquidas, não alcoólicas
WO2009061681A3 (en) Antagonists of pgd2 receptors
BRPI0508098A (pt) compostos, composições farmacêuticas e métodos para uso no tratamento de distúrbios metabólicos
TN2011000161A1 (en) Fgf21 mutants and uses thereof
MX346396B (es) Mutantes fgf21 y usos de los mismos.
WO2006101955A3 (en) Liquid coating compositions
MY156542A (en) Fgf21 mutants and uses thereof
WO2007041511A3 (en) Hematopoietic progenitor kinase 1 for modulation of an immune response
WO2006053010A3 (en) Use of antioxidants for gene modulation
MX2010006466A (es) Moleculas de union al receptor ox40 de humano.
ATE480223T1 (de) Kosmetische zusammensetzungen mit blockcopolymeren und entsprechendes system von dauerhaften kosmetikprodukten
UY31067A1 (es) Inhibidores de proteina activadora de la 5-lipoxigenasa (flap)
NO20065051L (no) Bazedoksifenacetat faste dispersjonsfomuleringer
WO2010025421A3 (en) Modulators of myc, methods of using the same, and methods of identifying agents that modulate myc
WO2008073174A3 (en) Antimicrobial therapy
MX2010002028A (es) Metodos y composiciones para modular celulas t.
MX2010013913A (es) 5-fenil-isoxazol-3-carboxamidas que modulan hsp90 con actividad antitumoral.
NZ596813A (en) Drug delivery systems
WO2007041364A3 (en) Conjugates for modulating the immune tolerance
WO2009017719A3 (en) Modulators of ccr9 receptor and methods of use thereof
BR112014017220A2 (pt) composições aglutinantes e métodos para fabricar e utilizar as mesmas
WO2008027855A3 (en) Compositions and methods for modulating mtor signaling
WO2009040512A3 (en) Modulation of rsk
DK0852623T3 (da) Nukleinsyremolekyler kodende for proteiner, som medierer adhæsionen af Neisseria-celler til humane celler

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or rights